IndraLab

Statements


| 2

reach
"Downregulation of USP8 inhibits the survival of gefitinib-resistant non-small cell lung cancer (NSCLC) cells."

reach
"Knock-down of USP8 selectively decreases viability of gefitinib resistant NSCLC cells."